High risk of lifetime history of suicide attempts among CYP2D6 ultrarapid metabolizers with eating disorders.

Suppr

超能文献

作者信息

Peñas-Lledó E M, Dorado P, Agüera Z, Gratacós M, Estivill X, Fernández-Aranda F, Llerena A

出版信息

Mol Psychiatry. 2011 Jul;16(7):691-2. doi: 10.1038/mp.2011.5. Epub 2011 Feb 15.

DOI:10.1038/mp.2011.5

PMID:21321564

Abstract

摘要

相似文献

High risk of lifetime history of suicide attempts among CYP2D6 ultrarapid metabolizers with eating disorders.

Mol Psychiatry. 2011 Jul;16(7):691-2. doi: 10.1038/mp.2011.5. Epub 2011 Feb 15.

Association of CYP2D6 ultrarapid metabolizer genotype with deficient patient satisfaction regarding methadone maintenance treatment.

Drug Alcohol Depend. 2007 Jul 10;89(2-3):190-4. doi: 10.1016/j.drugalcdep.2006.12.018. Epub 2007 Jan 17.

Increased frequency of cytochrome P450 2D6 poor metabolizers among patients with metoprolol-associated adverse effects.

Clin Pharmacol Ther. 2002 Oct;72(4):429-37. doi: 10.1067/mcp.2002.127111.

Ten percent of North Spanish individuals carry duplicated or triplicated CYP2D6 genes associated with ultrarapid metabolism of debrisoquine.

Pharmacogenetics. 1999 Oct;9(5):657-60.

Attempted suicide and self-injury in patients diagnosed with eating disorders.

Compr Psychiatry. 2004 Nov-Dec;45(6):447-51. doi: 10.1016/j.comppsych.2004.07.011.

Suicidality in eating disorders: occurrence, correlates, and clinical implications.

Clin Psychol Rev. 2006 Oct;26(6):769-82. doi: 10.1016/j.cpr.2006.04.001. Epub 2006 Jul 27.

Low frequency of CYP2D6 poor metabolizers among schizophrenia patients.

Pharmacogenomics J. 2007 Dec;7(6):408-10. doi: 10.1038/sj.tpj.6500439. Epub 2007 Feb 27.

Re: no evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline.

Hum Psychopharmacol. 2005 Jan;20(1):61-2; author reply 63-4. doi: 10.1002/hup.659.

Ultrarapid metabolism of sparteine: frequency of alleles with duplicated CYP2D6 genes in a Danish population as determined by restriction fragment length polymorphism and long polymerase chain reaction.

Pharmacogenetics. 1998 Apr;8(2):119-23.

High frequency of CYP2D6 ultrarapid metabolizers in Spain: controversy about their misclassification in worldwide population studies.

Pharmacogenomics J. 2016 Oct;16(5):485-90. doi: 10.1038/tpj.2016.47. Epub 2016 Jun 7.

引用本文的文献

Outpatient Pharmacogenomic Screenings to Prevent Addiction, Overdose, and Suicide.

Innov Clin Neurosci. 2023 Dec 1;20(10-12):12-17. eCollection 2023 Oct-Dec.

A one-year follow-up study of treatment-compliant suicide attempt survivors: relationship of CYP2D6-CYP2C19 and polypharmacy with suicide reattempts.

Transl Psychiatry. 2022 Oct 18;12(1):451. doi: 10.1038/s41398-022-02140-4.

The Systems Biology of Drug Metabolizing Enzymes and Transporters: Relevance to Quantitative Systems Pharmacology.

Clin Pharmacol Ther. 2020 Jul;108(1):40-53. doi: 10.1002/cpt.1818. Epub 2020 Apr 11.

Consequences of Copy-Number Variation for Pharmacogenomics in Psychiatry.

Front Psychiatry. 2019 Jun 20;10:432. doi: 10.3389/fpsyt.2019.00432. eCollection 2019.

Integrating multi-omics biomarkers and postprandial metabolism to develop personalized treatment for anorexia nervosa.

Prostaglandins Other Lipid Mediat. 2017 Sep;132:69-76. doi: 10.1016/j.prostaglandins.2017.02.002. Epub 2017 Feb 21.

Personalized prescribing: a new medical model for clinical implementation of psychotropic drugs.

Dialogues Clin Neurosci. 2016 Sep;18(3):313-322. doi: 10.31887/DCNS.2016.18.3/ceap.

Pharmacogenetic research activity in Central America and the Caribbean: a systematic review.

Pharmacogenomics. 2016 Oct;17(15):1707-1724. doi: 10.2217/pgs-2016-0053. Epub 2016 Sep 16.

High frequency of CYP2D6 ultrarapid metabolizers in Spain: controversy about their misclassification in worldwide population studies.

Pharmacogenomics J. 2016 Oct;16(5):485-90. doi: 10.1038/tpj.2016.47. Epub 2016 Jun 7.

High frequency of CYP2D6 ultrarapid metabolizer genotypes in an Ashkenazi Jewish population from Argentina.

Pharmacogenomics J. 2017 Jul;17(4):378-381. doi: 10.1038/tpj.2016.27. Epub 2016 Apr 12.

A combined high CYP2D6-CYP2C19 metabolic capacity is associated with the severity of suicide attempt as measured by objective circumstances.

Pharmacogenomics J. 2015 Apr;15(2):172-6. doi: 10.1038/tpj.2014.42. Epub 2014 Aug 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验